APA

Artioli G., Grazia A., Mocellin S., Simone M., Borgato L., Lucia B., Cappetta A., Alessandro C., Bozza F., Fernando B., Zavagno G., Giorgio Z., Zovato S., Stefania Z., Marchet A., Alberto M., Pastorelli D. & Davide P. (20101110). Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. : Anticancer research.

Chicago

Artioli Grazia, Grazia Artioli, Mocellin Simone, Simone Mocellin, Borgato Lucia, Lucia Borgato, Cappetta Alessandro, Alessandro Cappetta, Bozza Fernando, Fernando Bozza, Zavagno Giorgio, Giorgio Zavagno, Zovato Stefania, Stefania Zovato, Marchet Alberto, Alberto Marchet, Pastorelli Davide and Davide Pastorelli. 20101110. Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. : Anticancer research.

Harvard

Artioli G., Grazia A., Mocellin S., Simone M., Borgato L., Lucia B., Cappetta A., Alessandro C., Bozza F., Fernando B., Zavagno G., Giorgio Z., Zovato S., Stefania Z., Marchet A., Alberto M., Pastorelli D. and Davide P. (20101110). Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. : Anticancer research.

MLA

Artioli Grazia, Grazia Artioli, Mocellin Simone, Simone Mocellin, Borgato Lucia, Lucia Borgato, Cappetta Alessandro, Alessandro Cappetta, Bozza Fernando, Fernando Bozza, Zavagno Giorgio, Giorgio Zavagno, Zovato Stefania, Stefania Zovato, Marchet Alberto, Alberto Marchet, Pastorelli Davide and Davide Pastorelli. Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer. : Anticancer research. 20101110.